Filing Details
- Accession Number:
- 0000899243-22-035725
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-14 17:43:46
- Reporting Period:
- 2022-11-11
- Accepted Time:
- 2022-11-14 17:43:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
730272 | Repligen Corp | RGEN | Biological Products, (No Disgnostic Substances) (2836) | 042729386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1606030 | Anthony Hunt | C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-11 | 25,000 | $33.87 | 203,265 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-11-11 | 25,000 | $200.00 | 178,265 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2022-11-11 | 25,000 | $0.00 | 25,000 | $33.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
34,246 | 2028-02-29 | No | 4 | M | Direct |
Footnotes
- Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
- This option is fully vested and exercisable.